1.
Steven Coutre, Alessandra Tedeschi, Tadeusz Robak, Paul M. Barr, Carolyn Owen, Osnat Bairey, Jan Burger, Cathy Zhou, Lori Styles, Danelle F. James, Thomas J. Kipps. Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma. Haematologica 2018;103(6):e249-e251; https://doi.org/10.3324/haematol.2017.175380.